PTEN and cancer: Results obtained also demonstrated that lapatinib reduced the phosphorylation levels of PTEN at T366, putatively through the glycogen synthase kinase 3 (GSK-3), playing a role in the destabilization of the protein, which leads to a more potent effect in the suppression of cancer cells proliferation [53].